Nutriband (NASDAQ: NTRB), a pioneer in the science of using novel transdermal solutions and other innovative technologies, has kicked off the new by becoming the first NASDAQ company to dual list digital shares on Upstream, a fully regulated global stock exchange for digital securities and NFTs. The company began trading on Upstream yesterday under the ticker symbol NTRB. According to the announcement, the dual listing is designed to provide Nutriband with access to a global, digital-first investor base; potential investors will be able to trade using USDC digital currency as well as credit, debit, PayPal and USD, which will unlock liquidity, enhance price discovery and globalize the opportunity to invest in the company. “We are proud to have a trailblazer like Nutriband as the first company to dual list on Upstream and offer its shares to an international investor base seeking streamlined access to U.S. companies,” said Upstream cofounder Mark Elenowitz in the press release.
To view the full press release, visit https://ibn.fm/HO8TB
About Nutriband Inc.
Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s lead product under development is an abuse deterrent fentanyl patch incorporating its AVERSA(TM) abuse deterrence technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion and accidental exposure of drugs with abuse potential. For more information about the company, please visit www.Nutriband.com.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
